SCHEMBL30867920

SCHEMBL30867920

COC1(c2nccc(C)c2C2CCN(C(=O)OC(C)(C)C)CC2)COC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 9/20 0.43
FAAH O00519 1/20 0.41
WNT3A P56704 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGDS O60760 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30911106 0.91 GPR119 (0.45) GPR119FAAHWNT3AKDM4EMAPT
SCHEMBL30867758 0.87 GPR119 (0.38) GPR119WNT3ADDB1CRBNLMNA
SCHEMBL30867816 0.87 DDB1 (0.33) GPR119FAAHWNT3AKDM4EMAPT
SCHEMBL38653881 0.82 RAF1 (0.32)
SCHEMBL30867846 0.80 GPR119 (0.36) GPR119WNT3ALMNANPSR1
SCHEMBL30867763 0.80 GPR119 (0.36) GPR119WNT3ALMNANPSR1
SCHEMBL38653858 0.79 GPR119 (0.46) GPR119FAAHWNT3AKDM4EMAPT
SCHEMBL30867709 0.79 GPR119 (0.36) GPR119DDB1CRBN
SCHEMBL38653063 0.79 GPR119 (0.41) GPR119FAAHKDM4EMAPTTHRB
SCHEMBL38653653 0.79 GPR119 (0.49) GPR119FAAHKDM4EMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598916-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2025-08-13 EP disclosed
EP-4598917-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2025-08-13 EP disclosed
WO-2024076674-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-04-11 WO disclosed
WO-2024076672-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-04-11 WO disclosed